Scarica l'app Stockscreener
55.07
1.68%
-0.94
Hinge Health Inc Borsa (HNGE) Ultime notizie
Baird initiates coverage on Hinge Health stock with Neutral rating By Investing.com - Investing.com Nigeria
Baird Initiates Hinge Health at Neutral With $56 Price Target - MarketScreener
Baird initiates coverage on Hinge Health stock with Neutral rating - Investing.com
Hinge Health Inc. (NYSE:HNGE) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Hinge Health IPO Date, Price, Terms, and Performance - Access IPOs
Hinge Health (NYSE:HNGE) Trading Up 0.5%Should You Buy? - MarketBeat
Trends in Public Interest in Digital Musculoskeletal Care: A Google Trends Analysis of Hinge Health From 2020 to 2025 - Cureus
Analysts Offer Insights on Healthcare Companies: Soleno Therapeutics (SLNO) and Hinge Health, Inc. Class A (HNGE) - The Globe and Mail
Piper Sandler maintains Overweight rating on Hinge Health stock, cites strong technology moats - Investing.com Australia
Hinge Health (NYSE:HNGE) Shares Gap DownHere's What Happened - MarketBeat
Hinge Health (NYSE:HNGE) Reaches New 52-Week HighShould You Buy? - MarketBeat
Hinge Health’s Growth Stands Out In Digital Health Market - Finimize
Hinge Health Announces Early Share Lock-Up Release - MSN
Hinge Health (NYSE:HNGE) Stock Price Up 5.7%Time to Buy? - MarketBeat
Piper Sandler raises Hinge Health stock price target to $70 on strong outlook - Investing.com
Hinge Health’s Strategic Initiatives and Growth Potential Drive Buy Rating - TipRanks
CCORF Maintains Hinge Health(HNGE.US) With Buy Rating, Maintains Target Price $61 - 富途牛牛
Hinge Health (NYSE:HNGE) Trading Down 7.1%Here's What Happened - MarketBeat
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Gilead Sciences (GILD) and Cytokinetics (CYTK) - The Globe and Mail
Baron Small Cap Fund is Excited to Invest in Hinge Health (HNGE). Here’s Why - Insider Monkey
Hinge Health (NYSE:HNGE) Price Target Raised to $65.00 - MarketBeat
Hinge Health (NYSE:HNGE) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat
Hinge Health (NYSE:HNGE) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - MarketBeat
Hinge Health (NYSE:HNGE) Given New $60.00 Price Target at Evercore ISI - MarketBeat
Morgan Stanley Raises Hinge Health (NYSE:HNGE) Price Target to $57.00 - MarketBeat
Bank of America Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock - MarketBeat
Hinge Health, Inc. Class A Common Stock (NYSE:HNGE) Stock Quote - FinancialContent
Hinge Health shares fall 1.26% intraday as Trump's import taxes raise economic concerns. - AInvest
Brokerages Set Hinge Health Inc. (NYSE:HNGE) Price Target at $49.86 - Defense World
Hinge Health Inc. (NYSE:HNGE) Given Average Rating of "Buy" by Analysts - MarketBeat
Morgan Stanley Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock - Defense World
Barclays Boosts Hinge Health (NYSE:HNGE) Price Target to $62.00 - MarketBeat
Needham & Company LLC Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock - MarketBeat
Hinge Health price target raised to $62 from $48 at Truist - Yahoo Finance
Hinge Health’s Strategic Growth and Market Positioning: A Buy Recommendation by Ryan MacDonald - TipRanks
0.57%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):